Edwards Lifesciences Corp (EW) concluded trading on Wednesday at a closing price of $92.93, with 7.04 million shares of worth about $653.8 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 26.66% during that period and on March 13, 2024 the price saw a gain of about 2.22%. Currently the company’s common shares owned by public are about 601.10M shares, out of which, 591.80M shares are available for trading.
Stock saw a price change of 5.21% in past 5 days and over the past one month there was a price change of 6.67%. Year-to-date (YTD), EW shares are showing a performance of 21.88% which increased to 21.29% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $60.57 but also hit the highest price of $94.87 during that period. The average intraday trading volume for Edwards Lifesciences Corp shares is 4.25 million. The stock is currently trading 6.13% above its 20-day simple moving average (SMA20), while that difference is up 14.00% for SMA50 and it goes to 18.86% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Edwards Lifesciences Corp (NYSE: EW) currently have 601.10M outstanding shares and institutions hold larger chunk of about 82.57% of that.
The stock has a current market capitalization of $55.88B and its 3Y-monthly beta is at 1.04. PE ratio of stock for trailing 12 months is 40.38, while it has posted earnings per share of $2.30 in the same period. Its PEG reads 4.33 and has Quick Ratio of 2.40 while making debt-to-equity ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EW, volatility over the week remained 2.51% while standing at 2.15% over the month.
Analysts are in expectations that Edwards Lifesciences Corp (EW) stock would likely to be making an EPS of $0.64 in the current quarter, while forecast for next quarter EPS is $0.7 and it is $3.09 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.63 which is $0.66 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.62 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 9.76% while it is estimated to increase by 12.40% in next year. EPS is likely to shrink at an annualized rate of 9.34% for next 5-years, compared to annual growth of 15.35% made by the stock over the past 5-years.
Coverage by Wells Fargo stated Edwards Lifesciences Corp (EW) stock as an Overweight in their note to investors on February 02, 2024, suggesting a price target of $94 for the stock. Stock get an Underperform rating from Wolfe Research on November 28, 2023.
